drugset / Trial / NCT03009474

Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male Volunteers

NCT03009474

Phase 1 Completed 52 enrolled HK inno.N Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

To compare the pharmacokinetics and safety after a single dose administration of CJ-30060 and Exforge® 5/160mg, Crestor 10mg in healthy male volunteers.

Timeline

Start
2015-02
Primary completion
2015-04
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amlodipine Other / unclassified 5 mg
Comparator Rosuvastatin Small molecule 10 mg
Comparator Valsartan Small molecule 160 mg